CRJ: Q1 2025 saw record profitability and robust sales, with StarRupture development accelerating

About this update from Creepy Jar S.a.

Revenue and net profit grew 17% and 51% year-over-year, driven by strong Green Hell sales and cost control. StarRupture development remains the main investment focus, with high liquidity and no significant risks identified.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Creepy Jar S.a.